Business · 11/03/2020Updated: 10/17/2026 · 1 min read
FDA Announces Public Meeting to Discuss Inclusion of Pregnant Women in Clinical Trials
Summary
The FDA is hosting a public meeting to gather input from industry, patients, clinicians, and other stakeholders on the inclusion of pregnant women in clinical trials for drug development, a topic of scientific and ethical consideration.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →